Related Experiment Video

Updated: Jun 21, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Lipoprotein(a): a causal independent risk factor for coronary heart disease?

Vilmundur Gudnason1

  • 1Icelandic Heart Association Research Institute, Kopavogur, Iceland. v.gudnason@hjarta.is

Current Opinion in Cardiology
|July 23, 2009
PubMed

Insights

Lipoprotein(a) [Lp(a)] is a moderate risk factor for coronary heart disease (CHD). Genetic studies confirm LPA gene influence, but its impact on CHD risk prediction remains limited, requiring further research.

Area of Science:

  • Cardiovascular Genetics
  • Biochemistry
  • Epidemiology

Background:

  • Lipoprotein(a) [Lp(a)] is an established independent risk factor for coronary heart disease (CHD).
  • Lp(a) levels are primarily determined by the LPA gene locus.
  • Recent genetic research has focused on the LPA gene's role in cardiovascular risk.

Purpose of the Study:

  • To contextualize lipoprotein(a) research within recent genetic discoveries.
  • To evaluate the role of Lp(a) in coronary heart disease risk assessment.
  • To explore advances in understanding the genetic underpinnings of Lp(a) and CHD.

Main Methods:

  • Review of recent genetic studies on the LPA gene.
  • Analysis of Lp(a) as a risk factor for coronary heart disease.
  • Evaluation of the predictive value of Lp(a) in cardiovascular risk assessment.

Main Results:

  • Lp(a) is a confirmed independent, albeit moderate, risk factor for CHD.
  • Genetic studies reinforce the LPA gene's control over Lp(a) blood levels.
  • The LPA gene's contribution to CHD risk prediction is moderate and challenging to quantify.

Conclusions:

  • Suggestive evidence supports a causal link between Lp(a) levels and CHD.
  • Large-scale Mendelian randomization studies are needed to confirm causality.
  • The moderate effect and difficulty in lowering Lp(a) limit its clinical utility and public health impact.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...